CareRx Corporation (CHHHF)
USD 1.88
(-1.05%)
USD 1.88
(-1.05%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 89.8 Million CAD | -15.95% |
| 2022 | 106.85 Million CAD | 18.79% |
| 2021 | 89.94 Million CAD | 43.76% |
| 2020 | 62.57 Million CAD | -5.42% |
| 2019 | 66.15 Million CAD | -23.26% |
| 2018 | 86.2 Million CAD | 5.39% |
| 2017 | 81.79 Million CAD | -15.06% |
| 2016 | 96.29 Million CAD | -62.25% |
| 2015 | 255.07 Million CAD | -0.04% |
| 2014 | 255.17 Million CAD | -2.13% |
| 2013 | 260.72 Million CAD | 27.33% |
| 2012 | 204.76 Million CAD | 9.84% |
| 2011 | 186.41 Million CAD | 1264.76% |
| 2010 | 13.65 Million CAD | 69.21% |
| 2009 | 8.07 Million CAD | 301.69% |
| 2008 | -4 Million CAD | 0.66% |
| 2007 | -4.02 Million CAD | -632.0% |
| 2006 | -550.4 Thousand CAD | 2.71% |
| 2005 | -565.72 Thousand CAD | 8.12% |
| 2004 | -615.72 Thousand CAD | -204.44% |
| 2003 | 589.56 Thousand CAD | -56.54% |
| 2002 | 1.35 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 83.76 Million CAD | -6.73% |
| 2024 Q2 | 81.41 Million CAD | -2.08% |
| 2023 Q1 | 95.14 Million CAD | -10.96% |
| 2023 Q2 | 100.2 Million CAD | 5.31% |
| 2023 Q4 | 89.8 Million CAD | -8.15% |
| 2023 FY | 89.8 Million CAD | -15.95% |
| 2023 Q3 | 97.77 Million CAD | -2.43% |
| 2022 Q2 | 123.66 Million CAD | 17.35% |
| 2022 Q4 | 106.85 Million CAD | -10.15% |
| 2022 FY | 106.85 Million CAD | 18.79% |
| 2022 Q1 | 105.38 Million CAD | 17.16% |
| 2022 Q3 | 118.92 Million CAD | -3.84% |
| 2021 FY | 89.94 Million CAD | 43.76% |
| 2021 Q2 | 74.28 Million CAD | 37.23% |
| 2021 Q3 | 89.16 Million CAD | 20.03% |
| 2021 Q4 | 89.94 Million CAD | 0.88% |
| 2021 Q1 | 54.12 Million CAD | -13.49% |
| 2020 Q2 | 63.81 Million CAD | 9.1% |
| 2020 Q1 | 58.49 Million CAD | -11.58% |
| 2020 Q4 | 62.57 Million CAD | -0.66% |
| 2020 FY | 62.57 Million CAD | -5.42% |
| 2020 Q3 | 62.98 Million CAD | -1.29% |
| 2019 Q4 | 66.15 Million CAD | -37.12% |
| 2019 Q2 | 103.69 Million CAD | 6.53% |
| 2019 FY | 66.15 Million CAD | -23.26% |
| 2019 Q3 | 105.2 Million CAD | 1.46% |
| 2019 Q1 | 97.34 Million CAD | 12.93% |
| 2018 Q2 | 82 Million CAD | -3.82% |
| 2018 FY | 86.2 Million CAD | 5.39% |
| 2018 Q4 | 86.2 Million CAD | 4.15% |
| 2018 Q3 | 82.76 Million CAD | 0.93% |
| 2018 Q1 | 85.25 Million CAD | 4.23% |
| 2017 Q3 | 82.08 Million CAD | 5.97% |
| 2017 Q4 | 81.79 Million CAD | -0.35% |
| 2017 FY | 81.79 Million CAD | -15.06% |
| 2017 Q1 | 85.88 Million CAD | -10.82% |
| 2017 Q2 | 77.46 Million CAD | -9.81% |
| 2016 Q3 | 81.7 Million CAD | -3.53% |
| 2016 Q1 | 75.88 Million CAD | -70.25% |
| 2016 Q4 | 96.29 Million CAD | 17.86% |
| 2016 FY | 96.29 Million CAD | -62.25% |
| 2016 Q2 | 84.69 Million CAD | 11.6% |
| 2015 FY | 255.07 Million CAD | -0.04% |
| 2015 Q1 | 255.25 Million CAD | 0.03% |
| 2015 Q2 | 259.22 Million CAD | 1.55% |
| 2015 Q3 | 255.25 Million CAD | -1.53% |
| 2015 Q4 | 255.07 Million CAD | -0.07% |
| 2014 Q2 | 268.54 Million CAD | 2.47% |
| 2014 FY | 255.17 Million CAD | -2.13% |
| 2014 Q4 | 255.17 Million CAD | 2.99% |
| 2014 Q1 | 262.08 Million CAD | 0.52% |
| 2014 Q3 | 247.77 Million CAD | -7.74% |
| 2013 Q1 | 214.49 Million CAD | 4.75% |
| 2013 Q2 | 253.87 Million CAD | 18.36% |
| 2013 Q3 | 253.1 Million CAD | -0.3% |
| 2013 Q4 | 260.72 Million CAD | 3.01% |
| 2013 FY | 260.72 Million CAD | 27.33% |
| 2012 Q2 | 213.46 Million CAD | -3.48% |
| 2012 FY | 204.76 Million CAD | 9.84% |
| 2012 Q4 | 204.76 Million CAD | -1.83% |
| 2012 Q3 | 208.56 Million CAD | -2.29% |
| 2012 Q1 | 221.15 Million CAD | 18.64% |
| 2011 Q2 | 148.97 Million CAD | 1789.62% |
| 2011 Q4 | 186.41 Million CAD | 15.28% |
| 2011 Q3 | 161.7 Million CAD | 8.54% |
| 2011 FY | 186.41 Million CAD | 1264.76% |
| 2011 Q1 | 7.88 Million CAD | -42.28% |
| 2010 Q4 | 13.65 Million CAD | 81.97% |
| 2010 Q1 | 7.74 Million CAD | -4.09% |
| 2010 Q2 | 6.71 Million CAD | -13.24% |
| 2010 Q3 | 7.5 Million CAD | 11.75% |
| 2010 FY | 13.65 Million CAD | 69.21% |
| 2009 Q2 | 7.2 Million CAD | 302.09% |
| 2009 Q3 | 7.85 Million CAD | 9.03% |
| 2009 FY | 8.07 Million CAD | 301.69% |
| 2009 Q4 | 8.07 Million CAD | 2.72% |
| 2009 Q1 | -3.56 Million CAD | 10.89% |
| 2008 Q3 | -3.97 Million CAD | -22.45% |
| 2008 Q4 | -4 Million CAD | -0.67% |
| 2008 Q1 | -3.43 Million CAD | 14.8% |
| 2008 Q2 | -3.24 Million CAD | 5.41% |
| 2008 FY | -4 Million CAD | 0.66% |
| 2007 Q3 | -2.44 Million CAD | -234.99% |
| 2007 FY | -4.02 Million CAD | -632.0% |
| 2007 Q4 | -4.02 Million CAD | -64.5% |
| 2007 Q2 | -731.1 Thousand CAD | 19.21% |
| 2007 Q1 | -904.98 Thousand CAD | -64.42% |
| 2006 Q4 | -550.4 Thousand CAD | 36.11% |
| 2006 Q1 | -920.56 Thousand CAD | -62.72% |
| 2006 Q2 | -929.31 Thousand CAD | -0.95% |
| 2006 Q3 | -861.47 Thousand CAD | 7.3% |
| 2006 FY | -550.4 Thousand CAD | 2.71% |
| 2005 Q4 | -565.72 Thousand CAD | -23.78% |
| 2005 Q2 | -432.65 Thousand CAD | 21.37% |
| 2005 Q1 | -550.26 Thousand CAD | 10.63% |
| 2005 Q3 | -457.04 Thousand CAD | -5.64% |
| 2005 FY | -565.72 Thousand CAD | 8.12% |
| 2004 Q2 | 141.57 Thousand CAD | -69.23% |
| 2004 Q3 | -374.81 Thousand CAD | -364.75% |
| 2004 Q1 | 460.14 Thousand CAD | -21.95% |
| 2004 Q4 | -615.72 Thousand CAD | -64.27% |
| 2004 FY | -615.72 Thousand CAD | -204.44% |
| 2003 Q1 | -89 Thousand CAD | -106.56% |
| 2003 FY | 589.56 Thousand CAD | -56.54% |
| 2003 Q3 | 887.76 Thousand CAD | -15.45% |
| 2003 Q2 | 1.04 Million CAD | 1279.7% |
| 2003 Q4 | 589.56 Thousand CAD | -33.59% |
| 2002 Q3 | -217.28 Thousand CAD | 29.02% |
| 2002 Q4 | 1.35 Million CAD | 724.3% |
| 2002 FY | 1.35 Million CAD | 0.0% |
| 2002 Q2 | -306.1 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | -469.62 Thousand USD | 19223.221% |
| Arem Pacific Corporation | 181.02 Thousand USD | -49511.375% |
| Assisted 4 Living, Inc. | -199.71 Thousand USD | 45068.755% |
| BioCorRx Inc. | 5.56 Million USD | -1512.495% |
| Bionik Laboratories Corp. | 1.98 Million USD | -4424.501% |
| Banyan Corp. | 3.6 Million USD | -2390.12% |
| Clearday, Inc. | 44.86 Million USD | -100.161% |
| Dental Patient Care America, Inc. | -1.99 Million USD | 4597.157% |
| Quantum Medical Transport, Inc. | 1065.27 USD | -8430438.737% |
| Empower Clinics Inc. | 2.29 Million USD | -3806.654% |
| First Choice Healthcare Solutions, Inc. | 23.22 Million USD | -286.607% |
| Selectis Health, Inc. | 35.76 Million USD | -151.127% |
| Ethema Health Corporation | 14.51 Million USD | -518.746% |
| HealthLynked Corp. | 1.72 Million USD | -5101.677% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 13.79 Million USD | -551.096% |
| JRSIS Health Care Corporation | 911.83 Thousand USD | -9749.172% |
| Comjoyful International Company | -28.32 Thousand USD | 317117.897% |
| Medical Facilities Corporation | 92.22 Million USD | 2.617% |
| MedSmart Group Inc. | 659.56 Thousand USD | -13516.33% |
| North America Frac Sand, Inc. | 265.41 Thousand USD | -33736.822% |
| Nova Leap Health Corp. | -686.52 Thousand USD | 13181.515% |
| Nexteligent Holdings, Inc. | 1.83 Million USD | -4785.503% |
| PAO Group, Inc. | 639.37 Thousand USD | -13946.217% |
| Primemd Inc. | 4.54 Million USD | -1876.579% |
| Raffles Medical Group Ltd | -194.49 Million USD | 146.176% |
| Ryman Healthcare Limited | 1.51 Billion USD | 94.055% |
| Stem Cell Authority, Ltd. | 15.00 USD | -598719900.0% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.24 Million USD | -7124.403% |
| Mycotopia Therapies, Inc. | 811.51 Thousand USD | -10966.681% |
| U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | 23671.654% |
| Veltex Corporation | 2.17 Million USD | -4020.727% |
| World Financial Holding Group | 98.11 Thousand USD | -91435.271% |
| Xcelerate Inc. | 1.18 Million USD | -7493.055% |